Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$116.44 USD
+0.95 (0.82%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $116.47 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/30/2024
Time: BMO |
9/2024 | $1.47 | -10.31% |
Earnings Summary
For their last quarter, Neurocrine Biosciences (NBIX) reported earnings of $0.63 per share, missing the Zacks Consensus Estimate of $1.15 per share. This reflects a negative earnings surprise of 45.22%. Look out for NBIX's next earnings release on October 30, 2024. For the next earning release, we expect the company to report earnings of $1.47 per share, reflecting a year-over-year increase of 79.27%.
Earnings History
Price & Consensus
Zacks News for NBIX
Praxis Stock Up as Epilepsy Candidate Shows Reduction in Seizures
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services